Macrophage-Derived Angiopoietin-Like Protein 2 Exacerbates Brain Damage by Accelerating Acute Inflammation after

Toshihiro Amadatsu1,2, Jun Morinaga1, Takayuki Kawano2

  • 1Department of Molecular Genetics, Graduate school of Medical Sciences, Kumamoto University, 1-1-1 Honjo, Chuo-ku, Kumamoto, 860-8556, Japan.

Plos One
|November 19, 2016
PubMed

Insights

Angiopoietin-like protein 2 (ANGPTL2), secreted by infiltrating macrophages, exacerbates brain damage after ischemic stroke. Reducing ANGPTL2 levels in knockout mice significantly suppressed inflammation and brain injury, highlighting its role in stroke pathogenesis.

Area of Science:

  • Neuroscience
  • Immunology
  • Molecular Biology

Background:

  • Ischemic stroke is a major global health concern, leading to significant mortality and disability.
  • Acute inflammation post-ischemia-reperfusion is known to worsen brain damage, but the underlying molecular mechanisms are not fully understood.

Purpose of the Study:

  • To investigate the role of angiopoietin-like protein 2 (ANGPTL2) in acute brain inflammation and injury following ischemic stroke.
  • To elucidate the cellular sources and mechanisms by which ANGPTL2 contributes to brain damage in a mouse model of ischemic stroke.

Main Methods:

  • Utilized a transient middle cerebral artery occlusion (MCAO) model in wild-type and Angptl2 knockout (KO) mice.
  • Assessed neurological deficits and infarct volume.
  • Measured expression levels of pro-inflammatory cytokines (IL-1β, TNF-α).
  • Employed bone marrow chimeric models to distinguish the contribution of infiltrated macrophages.

Main Results:

  • Angiopoietin-like protein 2 (ANGPTL2) was highly expressed by MAC-3-positive immune cells (macrophages, microglia) in the ischemic mouse brain.
  • Angptl2 KO mice exhibited reduced neurological deficits and infarct volume compared to wild-type mice.
  • Acute brain inflammation, indicated by lower pro-inflammatory cytokine levels, was suppressed in Angptl2 KO mice.
  • Bone marrow chimeric studies demonstrated that infiltrated bone marrow-derived macrophages secreting ANGPTL2 significantly contribute to ischemia-reperfusion injury.

Conclusions:

  • Infiltrating bone marrow-derived macrophages promote inflammation and brain injury after ischemic stroke, primarily through the secretion of ANGPTL2 in the acute phase.
  • ANGPTL2 is a key mediator of post-ischemic inflammation and brain damage, representing a potential therapeutic target for ischemic stroke.